Search Results
Found 1 results
510(k) Data Aggregation
(287 days)
CRYO CHECK FACTOR XII DEFICIENT PLASMA MODEL FDP12-10 (1.0ML) AND FDP12-15 (1.5ML)
CryovCheck™ Factor XII Deficient Plasma is recommended for use as a substrate in clot-based Factor XII assays using the activated partial thromboplastin time (APTT) assay.
Cryo✓Check™ Factor XII Deficient Plasma is frozen human plasma deficient in the Factor XII coagulation factor. It is prepared from citrated pooled normal human plasma which has been depleted of Factor XII by immunoadsorption. Activity levels of Factor XII are assayed at less than 1% normal levels while all other coagulation factors are greater than 50%.
Acceptance Criteria and Study Details for Cryo✓Check™ Factor XII Deficient Plasma
The device's performance was evaluated through an "Open Vial Stability" study.
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria | Reported Device Performance (24 Hours) |
---|---|
Mean (+/-) 5% of reference value | 93 (within 5% of reference value, as 92.9% is the overall average) |
%C.V. |
Ask a specific question about this device
Page 1 of 1